Navigation

User login

Antiviral Drugs and H1N1 Flu (Swine Flu)

 Antiviral Drugs

Antiviral drugs are prescription medicines (pills, liquid or an inhaler) with activity against influenza viruses, including swine influenza viruses. Antiviral drugs can be used to treat swine flu or to prevent infection with swine flu viruses. These medications must be prescribed by a health care professional. Influenza antiviral drugs only work against influenza viruses -- they will not help treat or prevent symptoms caused by infection from other viruses that can cause symptoms similar to the flu.

There are four influenza antiviral drugs approved for use in the United States (oseltamivir, zanamivir, amantadine and rimantadine). The swine influenza A (H1N1) viruses that have been detected in humans in the United States and Mexico are resistant to amantadine and rimantadine so these drugs will not work against these swine influenza viruses. Laboratory testing on these swine influenza A (H1N1) viruses so far indicate that they are susceptible (sensitive) to oseltamivir and zanamivir.

 Benefits of Antiviral Drugs

Treatment: If you get sick, antiviral drugs can make your illness milder and make you feel better faster. They may also prevent serious influenza complications. Influenza antiviral drugs work best when started soon after illness onset (within two 2 days), but treatment with antiviral drugs should still be considered after 48 hours of symptom onset, particularly for hospitalized patients or people at high risk for influenza-related complications.

Prevention: Influenza antiviral drugs also can be used to prevent influenza when they are given to a person who is not ill, but who has been or may be near a person with swine influenza. When used to prevent the flu, antiviral drugs are about 70% to 90% effective. When used for prevention, the number of days that they should be used will vary depending on a person’s particular situation. 

 

CDC Recommendation

CDC recommends the use of oseltamivir or zanamivir for the treatment and/or prevention of infection with swine influenza viruses.

  • Oseltamivir (brand name Tamiflu ®) is approved to both treat and prevent influenza A and B virus infection in people one year of age and older.
  • Zanamivir (brand name Relenza ®) is approved to treat influenza A and B virus infection in people 7 years and older and to prevent influenza A and B virus infection in people 5 years and older.

Recommendations for using antiviral drugs for treatment or prevention of swine influenza will change as we learn more about this new virus.

Clinicians should consider treating any person with confirmed or suspected swine influenza with an antiviral drug. Visit: Interim Guidance on Antiviral Recommendations.

 

Stay informed with the latest news on the H1N1 (Swine Flu) virus updates.  Sign up to our newsletter.

Vaccine Shipment Status 


Vaccine Shipment Status 
by Project Area
Posted October 23, 2009, 12:00 PM ET
Project Areas*** Total Doses Shipped
as of 10/21/09**
Alabama 162,700
Alaska 31,600
American Samoa 0
Arizona 263,300
Arkansas 121,000
California 1,309,100
Chicago 158,700
Colorado 159,700
Connecticut 128,100
Delaware 15,700
District of Columbia 33,900
Federal Worker Program* 64,400
Florida 503,200
Georgia 353,000
Guam 9,500
Hawaii 58,200
Idaho 73,700
Illinois 507,800
Indiana 273,200
Iowa 135,000
Kansas 90,600
Kentucky 138,600
Louisiana 187,900
Maine 51,600
Marshall Islands 0
Maryland 229,800
Massachusetts 269,700
Michigan 308,300
Micronesia 5,100
Minnesota 117,100
Mississippi 73,800
Missouri 174,400
Montana 38,900
Nebraska 62,100
Nevada 103,900
New Hampshire 51,800
New Jersey 234,500
New Mexico 79,100
New York 311,700
New York City 417,400
North Carolina 321,900
North Dakota 30,900
Northern Mariana Islands 2,400
Ohio 434,500
Oklahoma 130,700
Oregon 144,000
Pennsylvania 471,500
Philadelphia 62,400
Puerto Rico 42,900
Republic of Palau 1,300
Rhode Island 18,700
South Carolina 158,700
South Dakota 39,900
Tennessee 241,100
Texas 831,400
Utah 110,200
Vermont 34,200
Virgin Islands 3,000
Virginia 315,700
Washington 227,500
West Virginia 89,600
Wisconsin 237,600
Wyoming 24,000
*For more information, please visit:http://www.opm.gov/pandemic/memos/h1n1_20090930.asp